F.H./B-ORG Faulding/I-ORG -AMP-/I-ORG Co./I-ORG ,/O an/O Australian/O pharmaceuticals/O company/O ,/O said/O its/O Moleculon/B-ORG Inc./I-ORG affiliate/O acquired/O Kalipharma/B-ORG Inc./I-ORG for/O $/O 23/O million/O ./O
Kalipharma/B-ORG is/O a/O New/B-GPE Jersey/I-GPE -/O based/O pharmaceuticals/O concern/O that/O sells/O products/O under/O the/O Purepac/O label/O ./O
Faulding/B-ORG said/O it/O owns/O 33/O %/O of/O Moleculon/B-ORG 's/O voting/O stock/O and/O has/O an/O agreement/O to/O acquire/O an/O additional/O 19/O %/O ./O
That/O stake/O ,/O together/O with/O its/O convertible/O preferred/O stock/O holdings/O ,/O gives/O Faulding/B-ORG the/O right/O to/O increase/O its/O interest/O to/O 70/O %/O of/O Moleculon/B-ORG 's/O voting/O stock/O ./O
